Cytosorbents Crp
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $9,617 | $8,727 | $6,523 | $8,613 |
Gross Profit | 6,814 | 6,208 | 6,771 | 4,504 |
EBITDA | -3,615 | -468 | -11,091 | -1,317 |
EBIT | -4,055 | -872 | -11,523 | -1,745 |
Net Income | 1,947 | -1,478 | -7,884 | -2,334 |
Net Change In Cash | 9,617 | 8,727 | 6,523 | 8,613 |
Free Cash Flow | -1,546 | -3,512 | -2,466 | -2,759 |
Cash | 10,204 | 11,587 | 3,279 | 5,685 |
Basic Shares | 67,166 | 60,732 | 54,715 | 54,453 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $35,594 | $31,084 | $29,360 | $40,109 |
Gross Profit | 25,125 | 21,953 | 15,404 | 29,061 |
EBITDA | -19,260 | -27,879 | -32,773 | -21,615 |
EBIT | -21,004 | -29,902 | -33,905 | -22,744 |
Net Income | -20,718 | -29,246 | -32,813 | -24,559 |
Net Change In Cash | 35,594 | 31,084 | 29,360 | 40,109 |
Cost of Revenue | -29,730 | -17,596 | ||
Free Cash Flow | -14,712 | -22,591 | -34,689 | -18,286 |
Cash | 3,279 | 14,131 | 22,145 | 52,138 |
Basic Shares | 54,434 | 44,656 | 43,573 | 43,359 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.05 |
2025-03-31 | -$0.14 |
2024-12-31 | -$0.14 |
